Table 1 Baseline characteristics and adherence to treatment of the included 1175 women, stratified by tamoxifen dose.

From: Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

  

Tamoxifen dose in mg

Characteristic

All

0

1

2.5

5

10

20

Number of women

1175

202

193

194

188

199

199

Mean age at baseline, years (SD)

55.7 (9.7)

56.4 (9.7)

54.5 (9.5)

55.3 (9.9)

55.5 (9.9)

56.5 (10.0)

55.9 (9.3)

Number of premenopausal women (%)

454 (38.6)

70 (34.7)

81 (42.0)

76 (39.2)

72 (38.3)

76 (38.2)

79 (39.7)

Number of postmenopausal women (%)

721 (61.4)

132 (65.3)

112 (58.0)

118 (60.8)

116 (61.7)

123 (61.8)

120 (60.3)

Mean age at menopause, years (SD)

50.0 (5.12)

50.0 (4.78)

50.0 (5.11)

50.3 (5.66)

49.6 (5.69)

49.3 (4.61)

50.4 (4.97)

Mean age at menarche, years (SD)

13.0 (1.36)

13.2 (1.40)

13.0 (1.39)

12.8 (1.37)

13.0 (1.32)

13.1 (1.37)

12.9 (1.32)

Mean BMI (SD)

25.4 (3.8)

25.0 (3.6)

25.5 (3.8)

25.8 (4.3)

25.6 (3.9)

25.4 (3.7)

25.4 (3.3)

Mean number of pregnancies (SD)

2.6 (1.6)

2.5 (1.4)

2.6 (1.6)

2.8 (1.6)

2.4 (1.6)

2.5 (1.5)

2.6 (1.7)

Mean age at first birth, years (SD)

28.8 (5.4)

28.7 (5.5)

28.8 (5.3)

29.0 (5.3)

28.7 (5.5)

28.8 (5.5)

28.9 (5.5)

Number of current smokers (%)

135 (12)

17 (8)

22 (11)

18 (9)

19 (10)

26 (13)

33 (17)

Mean gram/week of alcohol last year (SD)

49.4 (61.4)

53.6 (64.7)

48.9 (59.1)

43.3 (43.9)

49.4 (60.8)

53.7 (81.8)

47.5 (51.6)

Adherence

Compliant to treatmenta (%)

  All

996 (85.3)

182 (90.1)

170 (88.5)

159 (82.0)

152 (82.2)

164 (83.2)

169 (85.8)

  Premenopausal

393 (87.1)

62 (88.6)

71 (87.7)

64 (84.2)

64 (91.4)

65 (85.5)

67 (85.9)

  Postmenopausal

603 (84.2)

120 (90.9)

99 (89.2)

95 (80.5)

88 (76.5)

99 (81.8)

102 (85.7)

Number of women that discontinued treatment due to side effects (%)

  All

132 (11.2)

13 (6.4)

15 (7.8)

28 (14.4)

27 (14.4)

27 (13.6)

22 (11.1)

  Premenopausal

35 (7.7)

4 (5.7)

6 (7.4)

6 (7.9)

5 (6.9)

7 (9.2)

7 (8.9)

  Postmenopausal

97 (13.5)

9 (6.8)

9 (8.0)

22 (18.6)

22 (19.0)

20 (16.3)

15 (12.5)

  1. BMI body mass index, SD standard deviation.
  2. aCompliant to treatment: defined per protocol as 80 % of tablets taken. Missing information for 8 participants (3 premenopausal, 5 postmenopausal).